Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study.
Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study.
复制标题
作者:
Post-tuberculosis (post-TB) lung disease is an under-recognised consequence of pulmonary tuberculosis (pTB). We aimed to estimate the prevalence of residual lung function impairment and reduced health-related quality of life (HRQoL) in children after pTB treatment completion. We conducted a cross-sectional comparative study of children aged less than 15 years at TB diagnosis who had completed treatment for pTB at least 6 months previously with a comparator group of age-matched children without a history of pTB. Symptoms, spirometry and HRQoL measured with PedsQL scale were collected. Variables associated with lung function impairment were identified through logistic regression models. We enrolled 68 post-TB cases (median age 8.9 (IQR 7.2–11.2) years) and 91 children in the comparison group (11.5 (8.0–13.7) years). Spirometry from 52 (76.5%) post-TB cases and 89 (94.5%) of the comparison group met the quality criteria for acceptability and repeatability. Lung function impairment was present in 20/52 (38.5%) post-TB cases and 15/86 (17.4%) in the comparison group, p=0.009. Previous pTB and a history of chronic cough were significantly associated with the presence of lung function impairment (p=0.047 and 0.006 respectively). Forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC z-scores were significantly lower in the post-TB cases compared with the comparison group (p= <0.001, 0.014 and <0.001, respectively). The distribution of the self-reported physical health score, and parent-reported physical, emotional, psychological, social and total HRQoL scores were significantly lower in the post-TB cases compared with the comparison group. Previous TB in children is associated with significantly impaired lung function and HRQoL.
登录
查看更多内容
DOI:
10.1183/09031936.00080312
发表时间:
2012-12
期刊:
The European respiratory journal
影响因子:
--
作者:
Quanjer PH;Stanojevic S;Cole TJ;Baur X;Hall GL;Culver BH;Enright PL;Hankinson JL;Ip MS;Zheng J;Stocks J;ERS Global Lung Function Initiative
通讯作者:
ERS Global Lung Function Initiative
DOI:
10.1183/13993003.02325-2014
发表时间:
2015-10
期刊:
The European respiratory journal
影响因子:
--
作者:
Amaral AF;Coton S;Kato B;Tan WC;Studnicka M;Janson C;Gislason T;Mannino D;Bateman ED;Buist S;Burney PG;BOLD Collaborative Research Group
通讯作者:
BOLD Collaborative Research Group
DOI:
10.7196/ajtccm.2021.v27i2.135
发表时间:
2021
影响因子:
--
作者:
Ozoh OB;Ojo OO;Dania MG;Dede SK;Adegboyega OA;Irurhe NK;Olowoyeye M;Adeyeye OO
通讯作者:
Adeyeye OO
影响因子:
8
作者:
Chan, Johnny Y. C.;Stern, Debra A.;Martinez, Fernando D.
通讯作者:
Martinez, Fernando D.
影响因子:
5.8
作者:
Bush, Andrew
通讯作者:
Bush, Andrew